40,216 Shares in Axon Enterprise, Inc $AXON Purchased by J. Goldman & Co LP

J. Goldman & Co LP purchased a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 40,216 shares of the biotechnology company's stock, valued at approximately $22,545,000.

Other large investors have also added to or reduced their stakes in the company. EFG International AG purchased a new stake in shares of Axon Enterprise during the 2nd quarter worth approximately $22,097,000. Delos Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the 2nd quarter valued at approximately $45,000. Primecap Management Co. CA purchased a new position in shares of Axon Enterprise in the second quarter valued at $75,021,000. Canada Pension Plan Investment Board purchased a new position in shares of Axon Enterprise in the second quarter valued at $9,177,000. Finally, Castleark Management LLC bought a new stake in Axon Enterprise in the second quarter worth $13,131,000. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Price Performance

AXON stock opened at $613.26 on Wednesday. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $794.29. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The company has a 50-day moving average price of $549.76 and a 200 day moving average price of $479.31. The stock has a market cap of $49.82 billion, a PE ratio of 254.47, a P/E/G ratio of 9.70 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm's revenue for the quarter was up 35.3% on a year-over-year basis. During the same period in the prior year, the company posted $2.12 EPS. Equities research analysts anticipate that Axon Enterprise, Inc will post 2.04 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have commented on AXON. Morgan Stanley increased their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an "overweight" rating in a research report on Thursday, August 6th. TD Cowen restated a "buy" rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Citizens Jmp restated a "market outperform" rating and set a $700.00 target price on shares of Axon Enterprise in a research report on Thursday, June 25th. Zacks Research downgraded shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Friday, July 10th. Finally, Piper Sandler lifted their price target on Axon Enterprise from $724.00 to $732.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $730.92.

Insider Activity

In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of the stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the sale, the insider directly owned 34,024 shares in the company, valued at approximately $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 9,605 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the sale, the insider directly owned 97,761 shares of the company's stock, valued at $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 76,594 shares of company stock valued at $41,236,386. 4.20% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source